Cargando…
FOXD1 promotes chemotherapy resistance by enhancing cell stemness in colorectal cancer through β‑catenin nuclear localization
Forkhead box D1 (FOXD1) serves a critical role in colorectal cancer (CRC). FOXD1 expression is an independent prognostic factor in patients with CRC; however, the molecular mechanism and signaling pathway of FOXD1 that regulates cell stemness and chemoresistance has not been fully characterized. The...
Autores principales: | Feng, Wen-Qing, Zhang, Yu-Chen, Gao, Han, Li, Wen-Chang, Miao, Yi-Ming, Xu, Zi-Feng, Xu, Zhuo-Qing, Zhao, Jing-Kun, Zheng, Min-Hua, Zong, Ya-Ping, Lu, Ai-Guo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251342/ https://www.ncbi.nlm.nih.gov/pubmed/37203394 http://dx.doi.org/10.3892/or.2023.8571 |
Ejemplares similares
-
CXCL5 induces tumor angiogenesis via enhancing the expression of FOXD1 mediated by the AKT/NF-κB pathway in colorectal cancer
por: Chen, Chun, et al.
Publicado: (2019) -
Combination of FOXD1 and Plk2: A novel biomarker for predicting unfavourable prognosis of colorectal cancer
por: Zong, Yaping, et al.
Publicado: (2022) -
Retrospective research of neoadjuvant therapy on tumor-downstaging, post-operative complications, and prognosis in locally advanced rectal cancer
por: Li, Wen-Chang, et al.
Publicado: (2021) -
IRF3 prevents colorectal tumorigenesis via inhibiting the nuclear translocation of β-catenin
por: Tian, Miao, et al.
Publicado: (2020) -
Nuclear localization of TET2 requires β-catenin activation and correlates with favourable prognosis in colorectal cancer
por: Li, Changpeng, et al.
Publicado: (2023)